High-Density Lipoprotein Amyloid Proteins

Amyloid Proteins: The Beta Sheet Conformation and Disease

Volumn 2, Issue , 2008, Pages 589-623

  Kluve Beckerman, Barbara ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amyloidogenicity; Catabolism; Gene; High density lipoprotein; Protein structure

Indexed keywords

EID: 66449116234     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527619344.ch22     Document Type: Chapter

References (156)

1. Pras, M., M. Schubert, D. Zucker-Franklin, A. Rimon and E. Franklin. The characterization of soluble amyloid prepared in water. J Clin Invest 1968, 47, 924-933.
2. Husby, G., G. Marhaug, B. Dowton, K. Sletten and J. D. Sipe. Serum amyloid A (SAA): biochemistry, genetics and the pathogenesis of AA amyloidosis. Amyloid: Int J Clin Exp Invest 1994, 1, 119-137.
3. Uhler, C.M. and A. S. Whitehead. Serum amyloid A, the major vertebrate acutephase reactant. Eur J Biochem 1999, 265, 501-523.
4. Sipe, J. D. and A. S. Cohen. History of the amyloid fibril. J Struct Biol 2000, 130, 88-98.
5. Benson, M.D. Amyloidosis. In Arthritis and Allied Conditions: A Textbook of Rheumatology, 14th edn, W. J. Koopman (ed.). Lippincott Williams & Wilkins, Philadelphia, PA, 2001, pp. 1866-1895.
6. Sletten, K., K.H. Johnson and P. Westermark. The amino acid sequence of protein AA from a burro (Equus asinus). Amyloid: J Protein Folding Disord 2003, 10, 144-146.
7. Johnson, K. H., K. Sletten, L. Munson, T.D. O'Brien, R. Papendick and P. Westermark. Amino acid sequence analysis of amyloid protein A (AA) from cats (captive cheetahs: Acinoyx jubatus) with a high prevalence of AA amyloidosis. Amyloid: Int J Exp Clin Invest 1997, 4, 171-177.
8. Syverson, P.V., J. Juul, G. Marhaug, G. Husby and K. Sletten. The primary structure of serum amyloid A protein in sheep: comparison with serum amyloid A in other species. Scand J Immunol 1994, 39, 88-94.
9. Kluve-Beckerman, B., F. E. Dwulet, S.P. DiBartola and M.D. Benson. Primary structures of dog and cat amyloid A proteins: comparison to human AA. Comp Biochem Physiol 1989, 94B, 175-183.
10. Woo, P., M. Edbrooke, J. Betts, G. Watson and P. Francis, Serum amyloid A gene regulation. In Acute Phase Proteins: Molecular Biology, Biochemistry and Clinical Application, A. Mackiewicz, I. Kushner and H. Baumann (eds). CRC Press, Boca Raton, FL, 1993, pp. 397-408.
11. Sellar, G. C., K. Oghene, S. Boyle, W. A. Bickmore and A. S. Whitehead. Organization of the region encompassing the human serum amyloid A (SAA) gene family on chromosome 11p15.1. Genomics 1994, 23, 492-495.
12. Betts, J. C., M.R. Edbrooke, R.V. Thakker and P. Woo. The human acute-phase serum amyloid A gene family: structure, evolution, and expression in hepatoma cells. Scand J Immunol 1991, 34, 471-482.
13. Kluve-Beckerman, B. and M. Song. Genes encoding human serum amyloid A proteins SAA1 and SAA2 are located 18 kb apart in opposite transcriptional orientations. Gene 1995, 159, 289-290.
14. Whitehead, A. S., M.C. de Beer, D.M. Steel, M. Rits, J.M. Lelias, W. S. Lane and F. C. de Beer. Identification of novel members of the serum amyloid A protein superfamily as constitutive apolipoproteins of high density lipoprotein. J Biol Chem 1992, 267, 3862-3867.
15. Kluve-Beckerman B., M.L. Drumm and M.D. Benson. Non-expression of the human serum amyloid A three (SAA3) gene. DNA Cell Biol 1991, 10, 651-661.
16. Larson, M.A., S.H. Wei, A. Weber, A.T. Weber and T. L. McDonald. Induction of human mammary-associated serum amyloid A3 expression by prolactin or lipopolysaccharide. Biochem Biophys Res Commun 2003, 301, 1030-1037.
17. Lowell C. A., D.A. Potter, R.S. Stearman and J. F. Morrow. Structure of the murine serum amyloid A gene family. J Biol Chem 1986, 261, 8442-8452.
18. Butler, A. and A. S. Whitehead. Mapping of the mouse serum amyloid A gene cluster by long-range polymerase chain reaction. Immunogenetics 1996, 44, 468-474.
19. Stearman, R. S., C. A. Lowell, C.G. Peltzman and J. F. Morrow. The sequence and structure of a new serum amyloid A gene. Nucleic Acids Res 1986, 14, 797-809.
20. Sipe J. D., H. Rokita and F. C. de Beer. Cytokine regulation of the mouse SAA gene family. In Acute Phase Proteins: Molecular Biology, Biochemistry and Clinical Application, A. Mackiewicz, I. Kushner and H. Baumann (eds). CRC Press, Boca Raton, FL, 1993, pp. 511-526
21. de Beer, M. C., F. C. de Beer, W.D. McCubbin, C.M. Kay and M.S. Kindy. Structural prerequisites for serum amyloid A fibril formation. J Biol Chem 1993, 268, 20606-20612.
22. Sipe, J. D., I. Carreras, W. A. Gonnerman, E. S. Cathcart, M.C. de Beer and F. C. de Beer. Characterization of the inbred CE/J mouse strain as amyloid resistant. Am J Pathol 1993, 143, 1480-1485.
23. Meek, R. L., N. Ericksen and E. P. Benditt. Murine serum amyloid A3 is a high density apolipoprotein and is secreted by macrophages. Proc Natl Acad Sci USA 1992; 89, 7949-7952
24. de Beer, M. C., F. C. de Beer, C. J. Geradot, D. R. Cecil, M.R. Webb, M.L. Goodson and M.S. Kindy. Structure of the mouse Saa4 gene and its linkage to the serum amyloid A gene family. Genomics 1996, 34L, 139-142
25. de Beer, M. C., M.S. Kindy, W.S. Lane and F. C. de Beer. Mouse serum amyloid A protein (SAA5) structure and expression. J Biol Chem 1994, 269, 4661-4667.
26. Sipe, J. and Committee. Editorial Part 2. Revised nomenclature for serum amyloid A (SAA). Amyloid: Int J Exp Clin Invest 1999, 6, 67-70.
27. Faulkes, D. J., J. C. Betts and P. Woo. Characterization of five human serum amyloid A1 alleles. Amyloid: Int J Exp Clin Invest 1994, 1, 255-262.
28. Hoffman, J. S., L.H. Ericcson, E. Eriksen, K. A. Walsh and E. P. Benditt. Murine tissue amyloid protein AA, NH2-terminal sequence identity with only one of two serum amyloid proteins (apoSAA) gene products. J Exp Med 1984, 159, 641-646.
29. Liepnieks, J. J., B. Kluve-Beckerman and M.D. Benson. Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1. Biochim Biophys Acta 1995, 1270, 81-86.
30. Baba, A., T. Takahashi, T. Kasama, M. Fujie and H. Shirawasa. A novel polymorphism of human serum amyloid A protein, SAA1, is characterized by alanines at both residues 52 and 57. Biochim Biophys Acta 1992, 282, 615-620.
31. Baba, S., S. A. Masago, T. Takahashi, T. Kasama, H. Sugimura, S. Tsugane, Y. Tsutsui and H. Shirasawa. A novel allelic variant of serum amyloid A, SAA1 gamma: genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic AA-amyloidosis. Hum Mol Genet 1995, 4, 1083-1087.
32. Moriguchi, M., C. Terai, Y. Koseki, M. Uesato, A. Nakajima, S. Inada, M. Nishinarite, S. Uchida, A. Nakajima, S.Y. Kim, C. L. Chen and N. Kamatani. Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis. Hum Genet 1999, 105, 360-366.
33. Moriguchi, M., C. Terai, H. Kaneko, Y. Koseki, H. Kajiyama, M. Uesato, S. Inada and N. Kamatani. A novel single-nucleotide polymorphism at the 5́-lanking region of SAA1 associated with risk or type AA amyloidosis secondary to rheumatoid arthritis. Arthritis Rheum 2001, 44, 1266-1272.
34. Yamada, T., Y. Okuda, K. Takasugi, L. Wang, D. Marks, M.D. Benson and B. Kluve-Beckerman. An allele of serum amyloid A1 associated with amyloidosis in both Japanese and Caucasians. Amyloid: J Protein Folding Disord 2003, 10, 7-11.
35. Booth, D. R., S. E. Booth, J. D. Gillimore, P. N. Hawkins and M.B. Pepys. SAA1 alleles as risk factors in reactive systemic amyloidosis. Amyloid: Int J Exp Clin Invest 1998, 5, 262-265.
36. Cazeneuve, C., H. Ajrapetyan, S. Papin, F. Roudot-Thoraval, D. Genevieve, E. Mndjoyan, M. Papazian, A. Sarkisian, A. Babloyan, B. Boissier, P. Duguesnoy, J.-C. Kouyoumdjian, E. Girodon-Boulandet, G. Grateau, T. Sarkisian and S. Amselem. Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet 2000, 67, 1136-1143.
37. Medlej-Hashim, M., V. Delague, E. Chouery, N. Salem, M. Rawashdeh, G. Lefranc, J. Loiselet and A. Megarbane. Amyloidosis in familial Mediterranean fever patients: correlation with MEFV genotype and SAA1 and MICA polymorphisms effects. BMC Med Genet 2004, 5, 4.
38. Gershoni-Baruch, R., R. Brik, N. Zacks, M. Shinawi, M. Lidar and A. Livneh. The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum 2003, 48, 1149-1155.
39. Bakkaloglu, A., A. Duzova, S. Ozen, B. Balci, N. Besbas, R. Topaloglu, F. Ozaltin and E. Yilmaz. Influence of serum amyloid A (SAA1) and SAA2 gene polymorphisms on renal amyloidosis, and on SAA/C-reactive protein values in patients with familial Mediterranean fever in the Turkish population. J Rheumatol 2004, 31, 1139-1142.
40. Akar, N., M. Hasipek, E. Akar, M. Ekim, F. Yalcinkaya and N. Cakar. Serum amyloid A1 and tumor necrosis factor-alpha alleles in Turkish familial Mediterranean fever patients with and without amyloidosis. Amyloid: J Protein Folding Disord 2003, 10, 12-16.
41. Bausserman, L. L., P. N. Herbert, T. Forte, R. D. Klausner, K.P. McAdam, J. C. Osborne, Jr and M. Rosseneu. Interaction of the serum amyloid A proteins with phospholipid. J Biol Chem 1983, 258, 10681-10688.
42. Turnell, W. G., R. Sarra, I. D. Glover, J.O. Baum and D. Caspi. Secondary structure of human SAA1. Presumptive identification of calcium and lipid binding sites. Mol Biol Med 1986, 3, 387-407.
43. Patel, H., J. Bramall, H. Waters, M.C. de Beer and P. Woo. Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis. Biochem J 1996, 318, 1041-1049.
44. Westermark, G.T., U. Engstrom and P. Westermark. The N-terminal segment of protein AA determines its fibrillogenic property. Biochem Biophys Res Commun 1992, 182, 27-33.
45. McCubbin, W. D., C.M. Kay, S. Narindrasorasak and R. Kisilevsky. Circular-dichroism studies on two murine serum amyloid A proteins. Biochem J 1988, 256, 775-783.
46. Wang, L., H.A. Lashuel, T. Walz and W. Colón. Murine apolipoprotein serum amyloid A in solution forms a hexamer containing a central channel. Proc Natl Acad Sci USA 2002, 99, 15947-15952.
47. Wang, L. and W. Colón. The interaction between apolipoprotein serum amyloid A and high-density lipoprotein. Biochem Biophys Res Commun 2004, 317, 157-161.
48. Liang, J. S., B.M. Schreiber, M. Salmona, G. Phillip, W. A. Gonnerman, F. C. de Beer and J. D. Sipe. Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells. J Lipid Res 1996, 37, 2109-2116.
49. Sipe, J. D. Serum amyloid A: from fibril to function. Current status. Amyloid: Int J Exp Clin Invest 2000, 7, 10-12.
50. Mackiewicz, A., Kushner, I. and Baumann, H. (eds). Acute Phase Proteins: Molecular Biology, Biochemistry and Clinical Applications. CRC Press, Boca Raton, FL, 1993.
51. Schreiber, B.M. Editorial. Serum amyloid A; in search of function. Amyloid: J Protein Folding Disord 2002, 9, 279-280.
52. Li, L. and W. S. L. Liao. An upstream repressor element that contributes to hepatocyte-specific expression of the rat serum amyloid A1 gene. Biochem Biophys Res Commun 1999, 264, 395-403.
53. Jiang, S.-L., D. Samols, D. Rzewnicki, S. S. Macintyre, I. Greber, J. Sipe and I. Kushner. Kinetic Modeling and Mathematical analysis indicate that acute phase gene expression in Hep3B cells is regulated by both transcriptional and posttranscriptional mechanisms. J Clin Invest 1995, 95, 1253-1261.
54. Oram, J. F. Does serum amyloid A mobilize cholesterol from macrophages during inflammation? Amyloid: Int J Exp Clin Invest 1996, 3, 290-293.
55. Kisilevsky, R. and L. Subrahmanyan. Serum amyloid A changes high density lipoprotein's cellular affinity: a clue to serum amyloid A's principal function. Lab Invest 1992, 66, 778-785.
56. Banka, C. L., T. Yuan, M.C. de Beer, M. Kindy, L.K. Curtiss and F. C. de Beer. Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux. J Lipid Res 1995, 36, 1058-1065.
57. Steinmetz, A., G. Hocke, R. Saile, P. Puchois and J.-C. Fruchart. Influence of Serum amyloid A on cholesterol esterification in human plasma. Biochim Biophys Acta 1989, 1006, 173-178.
58. Lindhorst, E., D. Young, W. Bagshaw, M. Hyland and R. Kisilevsky. Acute inflammation, acute phase serum amyloid A and cholesterol metabolism in the mouse. Biochim Biophys Acta 1997, 1339, 143-154.
59. Pruzanski, W., E. Stefanski, F. C. de Beer, M.C. de Beer, P. Vadas, A. Ravandi and A. Kuksis. Lipoproteins are substrates for human secretory group IIA phospholipase A2: preferential hydrolysis of acute phase HDL. J Lipid Res 1998, 39, 2150-2160.
60. Bausserman, L. L., A. L. Van Saritelli, P. Zuiden, C. J. Gollaher and P. N. Herbert. Degradation of serum amyloid A by isolated perfused rat liver. J Biol Chem 1987, 262, 1583-1589.
61. Tape, C. and R. Kisilevsky. Apolipoprotein A-I and apolipoprotein SAA halflives during acute inflammation and amyloidogenesis. Biochim Biophys Acta 1990, 1043, 295-300.
62. Rocken C. and A. Shakespeare. Pathology, diagnosis and pathogenesis of AA amyloidosis. Virchows Arch 2002, 440, 111-122.
63. Rocken, C. and R. Kisilevsky. Comparison of the binding and endocytosis of high-density lipoprotein from healthy (HDL) and inflamed (HDLSAA) donors by murine macrophages of four different mouse strains. Virchows Arch 1998, 432, 547-555.
64. Chan, S. L., S. Chronopoulos, J. Murray, D.W. Laird and Z. Ali-Khan. Selective localization of murine ApoSAA1/SAA2 in endosomes-lysosomes in activated macrophages and their degradation products. Amyloid: Int J Exp Clin Invest 1997, 4, 40-48.
65. Kluve-Beckerman, B., J. J. Manaloor and J. J. Liepnieks. Binding, trafficking, and accumulation of serum amyloid A in peritoneal macrophages. Scand J Immunol 2001, 53, 393-400.
66. Yan, S. D., H. Zhu, A. Zhu, A. Golabek, H. Du, A. Roher, J. Yu, C. Soto, A.M. Schmidt, D. Stern and M. Kindy. Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat Med 2000, 6, 643-651.
67. Su, S. B., W.H. Gong, J. L. Gao, W. Shen, P.M. Murphy, J. J. Oppenheim and J.M. Wang. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J Exp Med 1999, 189, 395-402.
68. Shirahama, T.S. and A. Cohen. Intralysosomal formation of amyloid fibrils. Am J Pathol 1975, 81, 101-116.
69. Takahashi, M., T. Yokota, H. Kawano, T. Gondo, T. Ishihara and F. Uchino. Ultrastructural evidence for intracellular formation of amyloid fibrils in macrophages. Virchows Arch A 1989, 415, 411-419.
70. Chronopoulos, S., S. L. Chan, M.J.H. Ratcliffe and Z. Ali-Khan. Colocalization of ubiquitin and serum amyloid A and ubiquitin-bound AA in the endosomes-lysosomes: a double immunogold electron microscopic study. Amyloid: Int J Exp Clin Invest 1995, 2, 191-194.
71. Miura K. and H. Shirasawa. Amyloid A (AA) fibril formation in renal tubules occurs intracytoplasmically, possibly at the site of membrane assembling structures. Amyloid: Int J Exp Clin Invest 1994, 1, 107-113.
72. Kluve-Beckerman, B., J. Manaloor and J. J. Liepnieks. A pulse-chase study tracking the conversion of macrophage-endocytosed serum amyloid A into extracellular amyloid. Arthritis Rheum 2002, 46, 1905-1913.
73. Shirahama, T., K. Miura, S.-T. Ju, R. Kisilevsky, E. Gruys, E. and A. Cohen. Amyloid enhancing factor-loaded macrophages in amyloid fibril formation. Lab Invest 1990, 62, 61-68.
74. Kluve-Beckerman, B., J. J. Liepnieks, L. Wang and M.D. Benson. A cell culture system for the study of amyloid pathogenesis: amyloid formation by murine peritoneal cells in the presence of recombinant serum amyloid A. Am J Pathol 1999, 155, 123-133.
75. Sipe, J. D., K. P.W. J. McAdam and F. Uchino. Biochemical evidence for the biphasic development of experimental amyloidosis. Lab Invest 1978, 38, 110-114.
76. Axelrad, M.A., R. Kisilevsky, J. Willmer, S. J. Chen and M. Skinner. Further characterization of amyloid-enhancing factor. Lab Invest 1982, 47, 139-141.
77. Johan, K., G. Westermark, U. Engstrom, A. Gustavsson, P. Hultman and P. Westermark. Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils. Proc Natl Acad Sci USA 1998, 95, 2558-2563.
78. Lundmark, K., G.T. Westermark, S. Nystrom, C. L. Murphy, A. Solomon and P. Westermark. Transmissibility of systemic amyloidosis by prion-like mechanism. Proc Natl Acad Sci USA 2002, 99, 6979-6984.
79. Kisilevsky, R. L., Lemieux, L. Boudreau, Y. Dun-Sheng and P. Fraser. New clothes for amyloid-enhancing factor (AEF): silk as AEF. Amyloid: Int J Exp Clin Invest 1999, 6, 98-106.
80. Yamada, T., B. Kluve Beckerman, J. J. Liepnieks and M.D. Benson. Fibril formation from recombinant human serum amyloid A. Biochim Biophys Acta 1994, 1226, 323-329.
81. Barter, P. J. and K. A. Rye. High density lipoproteins and coronary heart disease. Atherosclerosis 1996, 121, 1-12.
82. Assmann, G. and A.M. Gotto, Jr. HDL cholesterol and protective factors in atherosclerosis. Circulation 2004, 109 (23 Suppl 1), III8-14.
83. Tall, A. R. An overview of reverse cholesterol transport. Eur Heart J 1998, 19 (Suppl A), A31-A35.
84. Frank, P. G. and Y. L. Marcel. Apolipoprotein A-I: structure-function relationships. J Lipid Res 2000, 41, 853-872.
85. Brouillette, C. G., G.M. Anantharamaiah, J. A. Engler and D.W. Borhani. Structural models of human apolipoprotein A-I: a critical analysis and review. Biochim Biophys Acta 2001, 1531, 4-46.
86. Fielding, C. J. and P. E. Fielding. Cellular cholesterol efflux. Biochim Biophys Acta 2001, 1533, 175-189.
87. Karathanasis, S. K., V. I. Zannis and J. L. Breslow. Isolation and characterization of the human apolipoprotein A-I gene. Proc Natl Acad Sci USA 1983, 80, 6147-6151.
88. Shoulders, C. C., A. R. Kornblitt, B. S. Munro and F. E. Baralle. Gene structure of human apolipoprotein A1. Nucleic Acids Res 1983, 11, 2827-2837.
89. Zannis, V. I., S. K. Karathanasis, H.T. Keutmann, G. Goldberger and J. L. Breslow. Intracellular and extracellular processing of human apolipoprotein A-I: secreted apolipoprotein A-I isoprotein 2 is a propeptide. Proc Natl Acad Sci USA 1983, 80, 2574-2578.
90. Januzzi, J. L., N. Azrolan, A. O'Connell, K. Aalto-Setala and J. L. Breslow. Characterization of the mouse apolipoprotein Apoa-1/Apoc-3 gene locus: genomic, mRNA, and protein sequences with comparisons to other species. Genomics 1992, 14, 1081-1088.
91. Brewer, H.B. Jr, T. Fairwell, A. LaRue, R. Ronan, A. Houser and T. J. Bronzert. The amino acid sequence of human apoA-I, an apolipoprotein isolated from high density lipoproteins. Biochem Biophys Res Commun 1978, 80, 623-630.
92. Breslow, J. L., D. Ross, J. McPherson, H. Williams, D. Kurnit, A. L. Nussbaum, S. K. Karathanasis and V. I. Zannis. Isolation and characterization of cDNA clones for human apolipoprotein A-I. Proc Natl Acad Sci USA 1982, 79, 6861-6865.
93. Cheung, P. and L. Chan. Nucleotide sequence of cloned cDNA of human apolipoprotein A-I. Nucleic Acids Res 1983, 11, 3703-3715.
94. Law, S.W., G. Gray, H.B. Brewer, Jr. cDNA cloning of human apoA-I: amino acid sequence of preproapoA-I. Biochem Biophys Res Commun 1983, 112, 257-264.
95. Fitch, W.M. Phylogenies constrained by the crossover process as illustrated by human hemoglobins and a thirteen-cycle, eleven-amino-acid repeat in human apolipoprotein A-I. Genetics 1977, 86, 623-644.
96. McLachlan, A.D. Repeated helical pattern in apolipoprotein-A-I. Nature 1977, 267, 465-466.
97. Segrest, J. P., D.W. Garber, C.G. Brouillette, S. C. Harvey and G.M. Anantharamaiah. The amphipathic α-helix: a multifunctional structural motif in plasma apolipoproteins. Adv Protein Chem 1994, 45, 303-369.
98. Klon, A. E., J. P. Segrest and S. C. Harvey. Comparative models for human apolipoprotein A-I bound to lipid in discoidal high-density lipoprotein particles. Biochemistry 2002, 41, 10895-10905.
99. Narayanaswami, V. and R. O. Ryan. Molecular basis of exchangeable apolipoprotein function. Biochim Biophys Acta 2000, 1483, 5-36.
100. Sorci-Thomas, M.G. and M.J. Thomas. The effects of altered apolipoprotein AI structure on plasma HDL concentration. Trends Cardiovasc Med 2002, 12, 121-128.
101. Marcel, Y. L. and R. S. Kiss. Structurefunction relationships of apolipoprotein A-I: a flexible protein with dynamic lipid associations. Curr Opin Lipidol 2003, 14, 151-157.
102. Borhani, D.W., D.P. Rogers, J. A. Engler and C.G. Brouillette. Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation. Proc Natl Acad Sci USA 1997, 94, 12291-12296.
103. Borhani, D.W., J.A. Engler and C.G. Brouillette. Crystallization of truncated human apolipoprotein A-I in a novel conformation. Acta Crystallogr D Biol Crystallogr 1999, 55, 1578-1583.
104. Okon, M., P. G. Frank, Y. L. Marcel and R. J. Cushley. Heteronuclear NMR studies of human serum apolipoprotein A-I. Part I. Secondary structure in lipid-mimetic solution. FEBS Lett 2002, 517, 139-143.
105. Rye, K. A. and P. J. Barter. Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I. Arterioscler Thromb Vasc Biol 2004, 24, 421-428.
106. Rigotti, A., B. L. Trigatti, M. Penman, H. Rayburn, J. Herz and M. Krieger. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci USA 1997, 94, 12610-12615.
107. Connelly, M.A. and D. L. Williams. Scavenger receptor BI: a scavenger receptor with a mission to transport high density lipoprotein lipids. Curr Opin Lipidol 2004, 15, 287-295.
108. Van Allen, M.W., J.A. Frohlich and J. R. Davis. Inherited predisposition to generalized amyloidosis. Neurology 1969, 19, 10-25.
109. Nichols, W. C., F. E. Dwulet, J. Liepnieks and M.D. Benson. Variant apolipoprotein AI as a major constituent of a human hereditary amyloid. Biochem Biophys Res Commun 1988, 156, 762-768.
110. Nichols, W. C., R. E. Gregg, H.B. Brewer, Jr and M.D. Benson. A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy. Genomics 1990, 8, 318-323.
111. Rader, D. J., R. E. Gregg, M.S. Meng, J. R. Schaefer, M.R. Kindt, L. A. Zech, M.D. Benson and H.B. Brewer, Jr. In vivo metabolism of a mutant apolipoprotein, apoA-IIowa, associated with hypoalphalipoproteinemia and hereditary systemic amyloidosis. J Lipid Res 1992, 33, 755-763.
112. Genschel, J., R. Haas, M.J. Propsting and H.-J. Schmidt. Hypothesis: apolipoprotein A-I induced amyloidosis. FEBS Lett 1998, 430, 145-149.
113. Jones, L. A., J. A. Harding, A. S. Cohen and Skinner M. New USA family has apolipoprotein AI (Arg26) variant. In Amyloid and Amyloidosis 1990: Proc VIth Int Symp on Amyloidosis, J.B. Natvig, O. Forre, G. Husby, A. Husebeck, B. Skogen, K. Sletten and P. Westermark (eds). Kluwer, Dordrecht, 1991, pp. 385-388.
114. Vigushin, D.M., J. Gough, D. Allan, A. Alguacil, B. Penner, N.M. Pettigrew, G. Quinonez, K. Bernstein, S. E. Booth, D.R. Booth, A. K. Soutar, P.N. Hawkins and M.B. Pepys. Familial nephropathic systemic amyloidosis caused by apolipoprotein AI variant Arg26. Q J Med 1994, 87, 149-154.
115. Hawkins, P. N., A. Bybee, H.J. B. Goodman, H.J. Lachmann, D. Rowczenio, J. A. Gilbertson, J. O'Grady, N. Heaton, A. Stangou and M.B. Pepys. Phenotype, genotype and outcome in hereditary apoAI amyloidosis. In Amyloid and Amyloidosis: Proc Xth Int Symp on Amyloid, G. Grateau, R. A. Kyle and M. Skinner (eds). CRC Press, Boca Raton, FL, 2005, p. 316.
116. Booth, D. R., S.Y. Tan, S. E. Booth, J. J. Hsuan, N.F. Totty, O. Nguyen, T. Hutton, D.M. Vigushin, G.A. Tennent, W. L. Hutchinson, N. Thomson, A. K. Soutar, P.N. Hawkins and M.B. Pepys. A new apo-lipoprotein A I variant, Trp50Arg, causes hereditary amyloidosis. Q JMed 1995, 88, 695-702.
117. Soutar, A. K., P. N. Hawkins, D.M. Vigushin, G. A. Tennent, S. E. Booth, T. Hutton, O. Nguyen, N.F. Totty, T.G. Feest, J. J. Hsuan and M.B. Pepys. Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis. Proc Natl Acad Sci USA 1992, 89, 7389-7393.
118. Murphy, C. L., S. Wang, K. Weaver, T. K. Williams, M.A. Gertz, D.T. Weiss and A. Solomon. Apolipoprotein A-I amyloidosis associated with a novel mutant. In Amyloid and Amyloidosis: Proc Xth Int Symp on Amyloid, G. Grateau, R. A. Kyle and M. Skinner (eds). CRC Press, Boca Raton, FL, 2005, pp. 363-365.
119. Booth, D. R., S.Y. Tan, S. E. Booth, G. A. Tennent, W. L. Hutchinson, J. J. Hsuan, N.F. Totty, O. Truong, A. K. Soutar, P.N. Hawkins, M. Bruguera, J. Caballeria, M. Sole, J.M. Campistol and M.B. Pepys. Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene. J Clin Invest 1996, 97, 2714-2721.
120. Persey, M. R., D.R. Booth, S. E. Booth, R. Van Zyl-Smit, B. K. Adams, A. B. Fattaar, G.A. Tennent, P. N. Hawkins and M.B. Pepys. Hereditary nephropathic systemic amyloidosis caused by a novel variant apolipoprotein A-I. Kidney Int 1998, 53, 276-281.
121. Obici, L., G. Palladini, V. Perfetti, S. Marciano, M. Bruno, S. Giorgetti, V. Bellotti, E. Arbustini and G. Merlini. In Amyloid and Amyloidosis: Proc IXth Int Symp on Amyloid, M. Bely and A. Apathy (eds). David Apathy, Hungary, 2001, pp. 81-83.
122. Obici, L., G. Palladini, S. Giorgetti, V. Bellotti, G. Gregorini, E. Arbustini, L. Verga, S. Marciano, S. Donadei, V. Perfetti, L. Calabresi, C. Bergonzi, F. Scolari and G. Merlini. Liver biopsy discloses a new apolipoprotein A-I hereditary amyloidosis in several unrelated Italian families. Gastroenterology 2004, 126, 1416-1422.
123. Coriu, D., A. Dispenzieri, F. J. Stevens, C. L. Murphy, W. Shuching, D.T. Weiss and A. Solomon. Hepatic amyloidosis resulting from deposition of the apolipoprotein A-I variant Leu75Pro. Amyloid: J Protein Folding Disord 2003, 10, 215-233.
124. Hamidi Asl, L., J. J. Liepnieks, K. Hamidi Asl, T. Uemichi, G. Moulin, E. Desjoyaux, R. Loire, M. Delpech, G. Grateau and M.D. Benson. Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1. Am J Pathol 1999, 154, 221-227.
125. Hamidi Asl, K., J. J. Liepnieks, M. Nakamura, F. Parker and M.D. Benson. A novel apolipoprotein A-1 variant, Arg173Pro, associated with cardiac and cutaneous amyloidosis. Biochem Biophys Res Commun 1999, 257, 584-588.
126. Obici, L., V. Bellotti, P. Mangione, M. Stoppini, E. Arbustini, L. Verga, I. Zorzoli, E. Anesi, G. Zanotti, C. Campana, M. Viganò and G. Merlini. The new apolipoprotein A-I variant Leu174--Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide. Am J Pathol 1999, 155, 695-702.
127. Mangione, P., M. Sunde, S. Giorgetti, M. Stoppini, G. Esposito, L. Gianelli, L. Obici, L. Asti, A. Andreola, P. Viglino, G. Merlini and V. Bellotti. Amyloid fibrils derived from the apolipoprotein AI Leu174Ser variant contains elements of ordered helical structures. Protein Sci 2001, 10, 187-199.
128. Mendes de Sousa, M., C. Vital, D. Ostler, R. Fernandes, J. Pouget-Abadie, D. Carles and M.J. Saraiva. Apolipoprotein AI and transthyretin as components of amyloid fibrils in a kindred with Apo AI Leu178His amyloidosis. Am J Pathol 2000, 156, 1911-1917.
129. Braschi, S., T. A. Neville, M.C. Vohl and D.L. Sparks. Apolipoprotein A-I charge and conformation regulate the clearance of reconstituted high density lipoprotein in vivo. J Lipid Res 1999, 40, 522-532.
130. Blanco-Vaca, F., J. C. Escolà-Gil, J.M. Martín-Campos and J. Julve. Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein. J Lipid Res 2001, 42, 1727-173.
131. Tailleux, A., P. Duriez, J.-C. Fruchart and V. Clavey. Apolipoprotein A-II, HDL metabolism and atherosclerosis. Atherosclerosis 2002, 164, 1-13.
132. Martin-Campos, J. M., J. C. Escola-Gil, V. Ribas and F. Blanco-Vaca. Apolipoprotein A-II, genetic variation on chromosome 1q21-q24, and disease susceptibility. Curr Opin Lipidol 2004, 15, 247-253.
133. Deeb, S. S., K. Takata, R. L. Peng, G. Kajiyama and J. J. Albers. A splice-junction mutation responsible for familial apolipoprotein A-II deficiency. Am J Hum Genet 1990, 46, 822-827.
134. Moore, M.N., K.T. Kao, Y. K. Tsao and L. Chan. Human apolipoprotein A-II: nucleotide sequence of a cloned cDNA, and localization of its structural gene on human chromosome 1. Biochem Biophys Res Commun 1984, 123, 1-7.
135. Lackner, K. J., S.W. Law and H.B. Brewer, Jr. The human apolipoprotein A-II gene: complete nucleic acid sequence and genomic organization. Nucleic Acids Res 1985, 13, 4597-4608.
136. Knott, T. J., S. C. Wallis, M.E. Robertson, L.M. Priestley, M. Urdea, L. B. Rall and J. Scott. The human apolipoprotein AII gene: structural organization and sites of expression. Nucleic Acids Res 1985, 13, 6387-6398.
137. Middleton-Price, H.R., J. A. van den Berghe, J. Scott, T. J. Knott and S. Malcolm. Regional chromosomal localisation of APOA2 to 1q21-1q23. Hum Genet 1988, 79, 283-285.
138. Li, W.-H., M. Tanimura, C.-C. Luo, S. Datta and L. Chan. The apolipoprotein multigene family: biosynthesis, structure-function relationship, and evolution. J Lipid Res 1988, 29, 245-271.
139. Weber, J.L. and P. E. May. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 1989, 44, 388-396.
140. Dupuy-Gorce, A. M., E. Desmarais, S. Vigneron, C. Buresi, V. Nicaud, A. Evans, G. Luc, D. Arveiler, P. Marques-Vidal, F. Cambien, L. Tiret, A. Crastes de Paulet and G. Roizes. DNA polymorphisms in linkage disequilibrium at the 3́ end of the human APOAII gene: relationships with lipids, apolipoproteins and coronary heart disease. Clin Genet 1996, 50, 191-198.
141. Scott, J., T. J. Knott, L.M. Priestley, M.E. Robertson, D.V. Mann, G. Kostner, G. J. Miller and N.E. Miller. Highdensity lipoprotein composition is altered by a common DNA polymorphism adjacent to apoprotein AII gene in man. Lancet 1985, 1, 771-773.
142. Brewer, H. B., S. E. Lux, R. Ronan and K.M. John. Amino acid sequence of human apoLp-GlnII (apoA-II), an apolipoprotein isolated from the high density lipoprotein. Proc Natl Acad Sci USA 1972, 69, 1304-1308.
143. Miller, C. G., T.D. Lee, R. C. LeBoeuf and J. E. Shively. Primary structure of apolipoprotein A-II from inbred mouse strain BALB/c. J Lipid Res 1987, 28, 311-319.
144. Segrest, J. P., M.K. Jones, H. de Loof, C.G. Brouillette, Y.V. Venkatachalapathi and G.N. Anantharamaiah. The amphipathic helix in the exchangable apolipoproteins: a review of secondary structure and function. J Lipid Res 1992, 33, 141-166.
145. Chapman, M.J. Comparative analysis of mammalian plasma lipoproteins. Methods Enzymol 1986, 128, 70-143.
146. Kalopissis, A.D. and J. Chambaz. Transgenic animals with altered highdensity lipoprotein composition and functions. Curr Opin Lipidol 2000, 11, 149-153.
147. Kalopissis, A. D., D. Pastier and J. Chambaz. Apolipoprotein A-II: beyond genetic associations with lipid disorders and insulin resistance. Curr Opin Lipidol 2003, 14, 165-172.
148. Benson, M.D., J. J. Liepnieks, M. Yazaki, T. Yamashita, K. Hamidi Asl, B. Guenther and B. Kluve-Beckerman. A new human hereditary amyloidosis: The result of a stop-codon mutation in the apolipoprotein AII gene. Genomics 2001, 72, 272-277.
149. Weiss, S.W. and D.L. Page. Amyloid nephropathy of Ostertag with special reference to renal glomerular giant cells. Am J Pathol 1973, 72, 447-460.
150. Yazaki, M., J. J. Liepnieks, T. Yamashita, B. Guenther, M. Skinner and M.D. Benson. Renal amyloidosis caused by a novel stop-codon mutation in the apolipoprotein A-II gene. Kidney Int 2001, 60, 1658-1665.
151. Yazaki, M., J. J. Liepnieks, M.S. Barats, A.H. Cohen and M.D. Benson. Hereditary systemic amyloidosis associated with a new apolipoprotein AII stop codon mutation Stop78Arg. Kidney Int 2003, 64, 11-16.
152. Rowczenio, D., J. A. Gilbertson, A. Bybee, D. Hernandez and P. N. Hawkins. Hereditary amyloidosis in a Spanish family associated with a novel non-stop mutation in the gene for apolipoprotein AII. In Amyloid and Amyloidosis: Proc Xth Int Symp on Amyloid, G. Grateau, R. A. Kyle and M. Skinner (eds). CRC Press, Boca Raton, FL, 2005, p. 366.
153. Higuchi, K., T. Yonezu, K. Kogishi, A. Matsumura, S. Takeshita, A. Kohno, M. Matsushita, M. Hosokawa and T. Takeda. Purification and characterization of a senile amyloid-related antigenic substance (apoSASSAM) from mouse serum; apoSASSAM is an apoAII apolipoprotein of mouse high density lipoprotein. J Biol Chem 1986, 261, 12834-12840.
154. Higuchi, K., M. Hosokawa and T. Takeda. Senescence-accelerated mouse. Methods Enzymol 1999, 309, 674-686.
155. Kitagawa, K., J. Wang, T. Matsushita, K. Kogishi, M. Hosokawa, X. Fu, Z. Guo, M. Mori and K. Higuchi. Polymorphisms of mouse apolipoprotein A-II: seven alleles found among 41 inbred strains of mice. Amyloid: J Protein Folding Disord 2003, 10, 207-214.
156. Xing, Y, A. Nakamura, T. Korenaga, Z. Guo, J. Yao, X. Fu, T. Matsushita, K. Kogishi, M. Hosokawa, F. Kametani, M. Mori and K. Higuchi. Induction of protein conformational change in mouse senile amyloidosis. J Biol Chem 2002, 277, 33164-33169.